Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Candel Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · Needham, MA, United States

  1. PrincipalsCharles SchochChief Financial OfficerFrancesca BaroneChief Scientific OfficerPaul Peter TakChief Executive Officerand 3 more
  2. CompanyCandel Therapeutics, Inc.Needham, MA, United States
  3. Phone line+1 (617) 916-5445General business
Request a quote

Candel Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker CADL) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 6

Chief executive

Paul Peter TakChief Executive Officer

Chair & board

Paul B ManningDirector (Board)

Finance

Charles SchochChief Financial Officer

Technology & engineering

Seshu TyagarajanChief Technology Officer
Everyone else on file (2)
Francesca BaroneChief Scientific Officer
William Garrett NicholsChief Medical Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Charles Schoch — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Francesca Barone — Chief Scientific Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Paul Peter Tak — Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Seshu Tyagarajan — Chief Technology Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers